190 related articles for article (PubMed ID: 24795071)
1. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.
Pouwels HG; Van de Zande SM; Horspool LJ; Hoeijmakers MJ
Vet Rec; 2014 Jun; 174(25):633. PubMed ID: 24795071
[TBL] [Abstract][Full Text] [Related]
2. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
[TBL] [Abstract][Full Text] [Related]
3. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
Heldens JG; Pouwels HG; van Loon AA
Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
[TBL] [Abstract][Full Text] [Related]
5. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
[TBL] [Abstract][Full Text] [Related]
6. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
7. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study.
Daly JM; Sindle T; Tearle J; Barquero N; Newton JR; Corning S
Equine Vet J; 2007 Sep; 39(5):446-50. PubMed ID: 17910270
[TBL] [Abstract][Full Text] [Related]
8. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
Crouch CF; Daly J; Henley W; Hannant D; Wilkins J; Francis MJ
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):345-55. PubMed ID: 16098611
[TBL] [Abstract][Full Text] [Related]
9. Vaccine failure caused an outbreak of equine influenza in Croatia.
Barbic L; Madic J; Turk N; Daly J
Vet Microbiol; 2009 Jan; 133(1-2):164-71. PubMed ID: 18632226
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
[TBL] [Abstract][Full Text] [Related]
11. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses.
Chambers TM; Quinlivan M; Sturgill T; Cullinane A; Horohov DW; Zamarin D; Arkins S; García-Sastre A; Palese P
Equine Vet J; 2009 Jan; 41(1):87-92. PubMed ID: 19301588
[TBL] [Abstract][Full Text] [Related]
12. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
[TBL] [Abstract][Full Text] [Related]
13. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines.
Mumford JA; Jessett DM; Rollinson EA; Hannant D; Draper ME
Vet Rec; 1994 Feb; 134(7):158-62. PubMed ID: 8160328
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).
Galvin P; Gildea S; Arkins S; Walsh C; Cullinane A
Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):73-80. PubMed ID: 24224822
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak.
Bryant NA; Paillot R; Rash AS; Medcalf E; Montesso F; Ross J; Watson J; Jeggo M; Lewis NS; Newton JR; Elton DM
Vet Res; 2010; 41(2):19. PubMed ID: 19863903
[TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
19. Equine Influenza Virus and Vaccines.
Oladunni FS; Oseni SO; Martinez-Sobrido L; Chambers TM
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452521
[TBL] [Abstract][Full Text] [Related]
20. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.
Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Kondo T; Matsumura T; Gildea S; Cullinane A
Influenza Other Respir Viruses; 2016 Nov; 10(6):536-539. PubMed ID: 27465864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
